A dendritic cell-based vaccine effects on T cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.

Authors

H. Lyerly

H. K. Lyerly

Duke University Medical Center, Durham, NC

H. K. Lyerly , A. Hobeika , D. Niedzwiecki , T. Osada , J. Marshall , C. R. Garrett , D. Z. Chang , M. Aklilu , T. S. Crocenzi , D. J. Cole , S. Dessureault , S. D. Hsu , A. Bulusu , B. M. Clary , R. Annechiarico , G. Devi , V. Chadaram , T. M. Clay , M. Morse

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics - Clinical Pharmacology and Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Clinical Trial Registration Number

NCT00103142

Citation

J Clin Oncol 29: 2011 (suppl; abstr 2533)

Abstract #

2533

Poster Bd #

19

Abstract Disclosures

Similar Posters

Poster

2020 ASCO Virtual Scientific Program

Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial.

Multimodal fluorescence-guided surgery of colorectal peritoneal metastases, a phase I/II clinical trial.

First Author: Jan-Marie de Gooyer